Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

534 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mechanisms of disease: pulmonary arterial hypertension.
Schermuly RT, Ghofrani HA, Wilkins MR, Grimminger F. Schermuly RT, et al. Among authors: grimminger f. Nat Rev Cardiol. 2011 Jun 21;8(8):443-55. doi: 10.1038/nrcardio.2011.87. Nat Rev Cardiol. 2011. PMID: 21691314 Free PMC article. Review.
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadaş B, Schermuly RT, Weissmann N, Seeger W, Grimminger F. Ghofrani HA, et al. Among authors: grimminger f. J Am Coll Cardiol. 2004 Oct 6;44(7):1488-96. doi: 10.1016/j.jacc.2004.06.060. J Am Coll Cardiol. 2004. PMID: 15464333 Free article. Clinical Trial.
Reversal of experimental pulmonary hypertension by PDGF inhibition.
Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W, Grimminger F. Schermuly RT, et al. Among authors: grimminger f. J Clin Invest. 2005 Oct;115(10):2811-21. doi: 10.1172/JCI24838. J Clin Invest. 2005. PMID: 16200212 Free PMC article.
Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studies.
Voswinckel R, Enke B, Reichenberger F, Kohstall M, Kreckel A, Krick S, Gall H, Gessler T, Schmehl T, Ghofrani HA, Schermuly RT, Grimminger F, Rubin LJ, Seeger W, Olschewski H. Voswinckel R, et al. Among authors: grimminger f. J Am Coll Cardiol. 2006 Oct 17;48(8):1672-81. doi: 10.1016/j.jacc.2006.06.062. Epub 2006 Sep 26. J Am Coll Cardiol. 2006. PMID: 17045906 Free article. Clinical Trial.
Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy.
Schermuly RT, Pullamsetti SS, Kwapiszewska G, Dumitrascu R, Tian X, Weissmann N, Ghofrani HA, Kaulen C, Dunkern T, Schudt C, Voswinckel R, Zhou J, Samidurai A, Klepetko W, Paddenberg R, Kummer W, Seeger W, Grimminger F. Schermuly RT, et al. Among authors: grimminger f. Circulation. 2007 May 1;115(17):2331-9. doi: 10.1161/CIRCULATIONAHA.106.676809. Epub 2007 Apr 16. Circulation. 2007. PMID: 17438150
Fhl-1, a new key protein in pulmonary hypertension.
Kwapiszewska G, Wygrecka M, Marsh LM, Schmitt S, Trösser R, Wilhelm J, Helmus K, Eul B, Zakrzewicz A, Ghofrani HA, Schermuly RT, Bohle RM, Grimminger F, Seeger W, Eickelberg O, Fink L, Weissmann N. Kwapiszewska G, et al. Among authors: grimminger f. Circulation. 2008 Sep 9;118(11):1183-94. doi: 10.1161/CIRCULATIONAHA.107.761916. Epub 2008 Aug 25. Circulation. 2008. PMID: 18725486
Role of epidermal growth factor inhibition in experimental pulmonary hypertension.
Dahal BK, Cornitescu T, Tretyn A, Pullamsetti SS, Kosanovic D, Dumitrascu R, Ghofrani HA, Weissmann N, Voswinckel R, Banat GA, Seeger W, Grimminger F, Schermuly RT. Dahal BK, et al. Among authors: grimminger f. Am J Respir Crit Care Med. 2010 Jan 15;181(2):158-67. doi: 10.1164/rccm.200811-1682OC. Epub 2009 Oct 22. Am J Respir Crit Care Med. 2010. PMID: 19850946
Riociguat for pulmonary hypertension.
Ghofrani HA, Voswinckel R, Gall H, Schermuly R, Weissmann N, Seeger W, Grimminger F. Ghofrani HA, et al. Among authors: grimminger f. Future Cardiol. 2010 Mar;6(2):155-66. doi: 10.2217/fca.10.5. Future Cardiol. 2010. PMID: 20230258 Review.
Riociguat for the treatment of pulmonary hypertension.
Schermuly RT, Janssen W, Weissmann N, Stasch JP, Grimminger F, Ghofrani HA. Schermuly RT, et al. Among authors: grimminger f. Expert Opin Investig Drugs. 2011 Apr;20(4):567-76. doi: 10.1517/13543784.2011.565048. Epub 2011 Mar 11. Expert Opin Investig Drugs. 2011. PMID: 21391889 Review.
534 results